BNO
Click for more information
5.26% 20.0¢ bionomics limited

Ann: BNC105 Clinical Trial In Combination With Nivolumab, page-3

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. windshift
    593 Posts.
    lightbulb Created with Sketch. 24
    clock Created with Sketch.
    07/01/19
    12:41
    Post #: 37044076
    It's good news that BNO has moved forward with a new clinical trial. Combo treatment with Nivolumab could go reasonable well. Worth giving it a try. This has the benefit that BMS is standing on the sidelines - if the combo works better than the drug alone one might find a ready-made partner for further trials is lined up. GLTA
    BNO Price at posting: 11.5¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Things finally 'looking different' for up-and-down Hot Stock tip Stockland
right-arrow Created with Sketch.
RMS High-grade Gold and Copper findings drive excitement at Red Mountain’s Flicka Lake
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BNO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.